P. Kent Hawryluk
Board Member
MBX Biosciences, Inc. (MBX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About P. Kent Hawryluk
P. Kent Hawryluk is recorded as Board Member at MBX Biosciences, Inc. (MBX). MBX Biosciences, Inc. reported in an 8-K filed June 6, 2025 that P. Kent Hawryluk was appointed Class I director, effective June 5, 2025. The proxy statement of MBX Biosciences, Inc. reports total compensation of $2,990,867 for P. Kent Hawryluk in fiscal 2025, including a base salary of $625,000. Disclosed compensation is on record for 3 fiscal years. P. Kent Hawryluk has spoken on 1 earnings call and 3 other investor events across 1 company, most recently for MBX Biosciences, Inc. on June 12, 2026.
“to elect two Class I director nominees, Tiba Aynechi, Ph.D. and P. Kent Hawryluk, to the Company's Board of Directors, each to hold office until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2026-07-13
-
Start not stated–2026-07-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at MBX Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Steven Hoerter CEO, Chairman
- John Smither CFO
- Ed Mathers Board Member
- Edward T. Mathers Board Member
- Laurie Stelzer Board Member
- Ora Pescovitz Board Member
- Patrick J. Heron Board Member
- Steven Ryder Board Member
- Tiba Aynechi Board Member
- Tiba Aynechi, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | MBX Biosciences, Inc. (MBX) | President and Chief Executive Officer | $625,000 | $2,990,867 |
| 2024 | MBX Biosciences, Inc. (MBX) | President and Chief Executive Officer | $483,300 | $2,235,317 |
| 2023 | MBX Biosciences, Inc. (MBX) | President and Chief Executive Officer | $420,000 | $4,862,064 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.